The oncogenic role of PKCiota gene amplification and overexpression in Chinese non-small cell lung cancer

Lung Cancer

Volumn 84, Issue 2, 2014, Pages 190-195

  Luo, Qingquan ^a   Tang, Lili ^c   Lin, Hao ^a   Huang, Jia ^a   Zhang, Tianwei ^c   Liu, Yuanjie ^c   Wang, Jia ^c   Zhan, Ping ^c   Yin, Xiaolu ^c   Su, Xinying ^c   Ji, Qunsheng ^c   Yu, Dehua ^c   Xu, Lin ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b JIANGSU CANCER HOSPITAL   (China)

^c ASTRAZENECA   (United Kingdom)

Author keywords

Amplification; Chinese NSCLC; Overexpression; PKCiota

Indexed keywords

PROTEIN KINASE C IOTA; SMALL INTERFERING RNA; ISOENZYME; PROTEIN KINASE C; PROTEIN KINASE C LAMBDA;

ADULT; ARTICLE; ASIAN; CANCER CELL; CANCER PROGNOSIS; CAUCASIAN; CELL GROWTH; CHINESE; DISTANT METASTASIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DOSAGE; GENE SILENCING; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADENOCARCINOMA; CHINA; ENZYMOLOGY; GENE EXPRESSION; GENETICS; LUNG TUMOR; LYMPH NODE METASTASIS; METABOLISM; NON SMALL CELL LUNG CANCER; ONCOGENE; PATHOLOGY; SECONDARY; SEX RATIO; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CHINA; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; HUMANS; ISOENZYMES; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; ONCOGENES; PROTEIN KINASE C; SEX DISTRIBUTION;

EID: 84899490766     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2013.08.029     Document Type: Article

References (20)

1. Mok T.S., Zhou Q., Wu Y.-L. Research and standard care lung cancer in China. Am Soc Clin Oncol 2012, 432-436.
2. Globocan International Agency for Research of Cancer. ; 2008. http://globocan.iarc.fr/.
3. Kosaka T., Yatabe Y., Endoh H., Kuwano H., Takahashi T., Mitsudomi T. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res 2004, 64:8919-8923.
4. Marchetti A., Martella C., Felicioni L., et al. EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. J Clin Oncol 2005, 23:857-865.
5. Soda M., Choi Y.L., Enomoto M., Takada S., et al. Identification of the transforming EML4-ALK fusion gene in non small cell lung cancer. Nature 2007, 448:561-567.
6. Mok T.S., Wu Y.L., Thongprasert S., et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 2009, 361:947-957.
7. Kwak E.L., Bang Y.J., Camidge D.R., et al. Anaplastic lymphoma kinase inhibition in non-small cell lung cancer. N Engl J Med 2010, 363:1693-1703.
8. Shaw A.T., Yeap B.Y., Solomon B.J., et al. Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis. Lancet Oncol 2011, 12:1004-1012.
9. Heist R.S., Sequist L.V., Engelman J.A. Genetic changes in squamous cell lung cancer: a review. J Thorac Oncol 2012, 7(5):924-933.
10. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 1988, 334(6184):661-665.
11. Regala R.P., Weems C., Jamieson L., et al. Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer. Cancer Res 2005, 65(19):8905-8911.
12. Regala R.P., Weems C., Jamieson L., Copland J.A., Thompson E.A., Fields A.P. Atypical protein kinase Ciota plays a critical role in human lung cancer cell growth and tumorigenicity. J Biol Chem 2005, 280(35):31109-31115.
13. Balsara B.R., Sonoda G., du Manoir S., et al. Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. Cancer Res 1997, 57(11):2116-2120.
14. Brass N., Rácz A., Heckel D., et al. Amplification of the genes BCHE and SLC2A2 in 40% of squamous cell carcinoma of the lung. Cancer Res 1997, 57(11):2290-2294.
15. Hecht S.S. Lung carcinogenesis by tobacco smoke. Int J Cancer 2012, 131(12):2724-2732.
16. Jin Z., Xin M., Deng X. Survival function of protein kinase C{iota} as a novel nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-activated bad kinase. J Biol Chem 2005, 280(16):16045-16052.
17. Mehlen P., Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer J 2006, 6(6):449-458.
18. Murray N.R., Jamieson L., Yu W., et al. Protein kinase Ciota is required for Ras transformation and colon carcinogenesis in vivo. J Cell Biol 2004, 164(6):797-802.
19. Evans J.D., Cornford P.A., Dodson A., Neoptolemos J.P., Foster C.S. Expression patterns of protein kinase C isoenzymes are characteristically modulated in chronic pancreatitis and pancreatic cancer. Am J Clin Pathol 2003, 119(3):392-402.
20. Gustafson W.C., Ray S., Jamieson L., Thompson E.A., Brasier A.R., Fields A.P. Bcr-Abl regulates protein kinase Ciota (PKCiota) transcription via an Elk1 site in the PKCiota promoter. J Biol Chem 2004, 279(10):9400-9408.